Multi-Specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment

    August 2025 in “ Advances in Therapy ”
    Zhuowei Gu, Wei Chen, Jian Ming, Haijiao Liu, Hui‐Chuan Sun, Zhe Xu, Yijing Li, Yingyao Chen, Qinjie Tian
    Image
    Studysummary In this study, the researchers noted that physicians in China prioritize clinical hyperandrogenism when making PCOS treatment decisions, highlighting a need to align clinical practices with guidance recommendations and to clarify the role of biochemical hyperandrogenism in future guidelines.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study highlights that physicians' decisions on PCOS treatment in China are heavily influenced by the presence of clinical hyperandrogenism across various specialties, underscoring the importance of assessing hyperandrogenism in clinical practice. It suggests that the role of biochemical hyperandrogenism in PCOS treatment needs further clarification in future clinical guidelines. Additionally, there is an urgent need to align clinical practice with guidance recommendations for diagnosing and treating PCOS in China.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results